Catalyst Wire Dossier Catalyst Wire Dossier

Sodium phenylbutyrate tablets, 500 mg

Sodium phenylbutyrate · Endo USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sodium phenylbutyrate tablets, 500 mg, covering 2016-04-15 to 2016-04-15. Get the full timeline:

Most recent: FDA Approved: SODIUM PHENYLBUTYRATE — Original Application (ENDO USA, Inc.)

See pricing